Balyasny Asset Management
NBSE

Balyasny Asset Management’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Balyasny Asset Management’s Portfolio NBSE Stock Details NBSE Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
2018
Q1 		$5K Buy
2016
Q1 		– Sell
2015
Q4 		$172K Buy
2015
Q3 		$66K Buy
2015
Q2 		$49K Buy